Equities

Coltene Holding AG

Coltene Holding AG

Actions
Health CareMedical Equipment and Services
  • Price (CHF)50.60
  • Today's Change0.40 / 0.80%
  • Shares traded237.00
  • 1 Year change-24.14%
  • Beta0.8868
Data delayed at least 15 minutes, as of Nov 22 2024 10:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.

  • Revenue in CHF (TTM)238.80m
  • Net income in CHF12.34m
  • Incorporated2005
  • Employees1.19k
  • Location
    Coltene Holding AGFeldwiesenstrasse 20ALTSTAETTEN 9450SwitzerlandCHE
  • Phone+41 717575380
  • Fax+41 717575301
  • Websitehttps://www.coltene.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Detection Technology Oyj-92.88bn-92.88bn189.21m464.00--2.76----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
BICO Group AB180.57m-63.08m191.71m828.00--0.8285--1.06-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Onward Medical NV0.00-32.65m193.16m99.00--7.67-----1.09-1.090.000.60790.00----0.00-66.40-55.70-79.20-61.60-------79,513.95----0.4855---34.62---10.40--32.59--
Medistim ASA43.81m8.14m207.07m152.0025.416.3720.424.735.555.5529.8722.121.130.74617.483,599,204.0021.0522.9325.5328.5279.1278.2518.5820.642.75--0.018175.257.0010.06-8.9112.720.03314.87
Tristel Plc46.81m7.24m234.16m213.0032.606.4522.815.000.1350.1350.87140.68180.98121.815.74--15.189.3217.7510.7680.0880.7515.4711.093.04--0.1532109.3516.459.8945.469.9910.1319.53
Nyxoah SA4.72m-49.21m252.11m147.00--2.59--53.41-1.72-1.720.1663.040.03660.55692.3034,618.53-38.20-23.73-42.88-25.9861.7562.42-1,042.52-1,469.594.95-45.270.1822--40.99---38.39--100.58--
COLTENE Holding AG238.80m12.34m299.97m1.19k24.353.0015.621.262.062.0639.8916.731.271.386.06198,668.906.5510.4811.7018.7464.9062.685.177.470.861910.180.342179.94-9.133.54-54.05-6.81-7.72-7.79
Guerbet SA767.39m30.43m308.78m2.92k10.480.85333.720.40242.512.5166.4230.820.81280.54935.56282,958.603.031.404.961.8678.5876.023.731.821.163.850.507357.824.30-0.0993158.05-12.615.23-10.07
Stratec SE232.69m9.30m312.79m1.46k33.631.4811.501.340.82360.823620.6118.740.56051.275.32164,609.702.247.072.858.2027.0427.324.009.700.92693.860.401140.81-4.636.88-55.293.30-2.16-7.68
Synektik SA133.60m18.10m318.79m164.0017.627.7615.252.399.929.9273.2522.521.8426.956.41--24.9815.0939.9723.8326.8224.8813.5511.001.4945.180.109--39.8235.9061.3656.0850.89--
IVF Hartmann Holding AG152.90m17.64m350.40m298.0019.862.4814.962.297.357.3563.7258.840.87883.148.52502,947.4010.147.2912.068.9055.2153.2911.548.303.95--0.005852.16-1.792.0934.951.49-14.8326.82
medmix AG479.70m-1.80m356.51m2.70k--0.76466.190.7432-0.05-0.0511.3511.300.47783.405.58180,474.00-0.09962.06-0.12272.4932.5836.38-0.20854.161.062.210.436167.701.991.40-97.41-64.3612.01--
Ion Beam Applications SA432.58m7.29m371.25m1.84k49.104.2720.390.85820.26890.268915.993.090.77212.152.70234,517.101.301.556.014.3234.1935.231.692.380.63723.770.399264.8318.6710.74-250.40---8.06--
CellaVision AB59.10m12.04m410.15m228.0034.066.6626.676.946.306.3030.9132.190.78491.917.263,233,162.0015.9915.3018.4518.2466.9969.0320.3819.982.151,358.860.044110.185.9413.1710.128.0030.458.45
RaySearch Laboratories AB (publ)93.72m14.03m426.08m414.0039.118.4412.774.555.105.1034.0923.650.60235.513.293,005,152.009.021.2913.691.8891.0690.5714.972.551.27108.610.370669.0021.1610.26243.060.7648-1.31--
Data as of Nov 22 2024. Currency figures normalised to Coltene Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

14.35%Per cent of shares held by top holders
HolderShares% Held
UBS Asset Management Switzerland AGas of 31 Dec 2023191.22k3.20%
Credit Suisse Asset Management (Schweiz) AGas of 31 Dec 2023165.52k2.77%
Tweedy, Browne Co. LLCas of 28 Jun 2024148.68k2.49%
Reichmuth & Co.as of 30 Jun 202365.00k1.09%
Investor Asset Management BVas of 08 Nov 202458.33k0.98%
Z�rcher Kantonalbank (Investment Management)as of 30 Aug 202452.08k0.87%
L�hiTapiola Varainhoito Oyas of 30 Sep 202451.24k0.86%
Dimensional Fund Advisors LPas of 07 Nov 202448.00k0.80%
LLB Asset Management AGas of 31 Oct 202441.37k0.69%
Fourton Fund Management Co. Ltd.as of 30 Jun 202436.00k0.60%
More ▼
Data from 30 Jun 2024 - 08 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.